Real Estate team advises Jazz Pharmaceuticals on $100 million manufacturing facility in Kent

2 minute read
23 June 2022

International law firm Gowling WLG has advised Jazz Pharmaceuticals on its new 60,000 sq. ft, state-of-the-art manufacturing facility, representing an investment of over $100 million (approximately £75 million).

Gowling WLG advised Jazz Pharmaceuticals on all aspects of the transaction including tax, real estate, construction and planning. The team that worked on the project was led by Simon Wood and Helen Emmerson with support from partners Paul Green (Construction), Lee Nuttall (Tax) and Ben Stansfield (Environmental), legal director Tim Sharp (Planning) and principal associate Heather Manning (Real Estate).

Simon Wood and Helen Emmerson, both Real Estate partners at Gowling WLG, said: "We're delighted to have worked with our longstanding client Jazz Pharmaceuticals on accomplishing this excellent result which will help them to achieve their growth strategy objectives. We'd also like to extend our thanks to Gordon Reynolds at Cushman & Wakefield for his expert advice and unstinting effort on the project."

Gowling WLG is home to one of the UK's largest Real Estate practices. For further information, please visit our Real Estate sector page.


NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.